TAS2R20 and esophageal adenocarcinoma: Notably, statistically significant survival associations were identified for TAS2R5 in cervical squamous cell carcinoma (p < 0.001), TAS2R20 in esophageal adenocarcinoma (p = 0.044), and TAS2R4, TAS2R20, and TAS1R3 in prostate adenocarcinoma (p = 0.03, p = 0.033, and p = 0.023, respectively).